+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Risk factors and prognosis of lung cancer combined with pulmonary embolism



Risk factors and prognosis of lung cancer combined with pulmonary embolism



Zhongguo Fei Ai Za Zhi 14(10): 780-784



Malignant tumors often combined with venous thrombosis and pulmonary embolism, especially in lung cancer. It has been proven that, the mechanisms and risk factors for lung cancer patients contracting pulmonary embolism are unclear. The aim of this study is to summarize the clinical data on 54 patients with lung cancer and concomitant pulmonary embolism, and to analyze the risk factors and prognosis of lung cancer with pulmonary thromboembolism (PTE). From April 1999 to January 2010, the clinical presentation of lung cancer patients with PTE from the Jiangsu Cancer Hospital and the Jiangsu Gerontic Institute were evaluated in the present retrospective study. Univariate analysis was conducted to determine the possible associated variables. Conditional logistic regression analysis was applied to explore risk factors of pulmonary embolism. Patient survival was also compared with matched controls via a Log-rank test. A total of 54 lung cancer patients with PTE, matched with 162 lung cancer patients as controls, were included. In the univariate analysis, a P<0.20 was considered as possible risk factor, which was included into the logistic regression model. The logistic regression model showed that the OR combined with pulmonary embolism was 2.64 in patients receiving chemotherapy, 2.25 in patients with stage III-IV disease, 2.39 in patients combined with chronic obstructive pulmonary disease (COPD), 2.12 in patients with adenocarcinoma, 2.10 in patients with serum hemoglobin>140 g/L, and 1.76 in patients with central venous catheters. A significant difference was observed among the groups that received chemotherapy, adenocarcinoma, stage III-IV disease and high henoglobin (P<0.05). The survival time in patients with pulmonary embolism was remarkably lower than that in patients without pulmonary embolism (P=0.02). Chemotherapy, late stage disease and high serum hemoglobin are important risk factors for lung cancer patients with concomitant pulmonary embolism. The survival time of these patients is significantly lower than that in patients without pulmonary embolism.

(PDF emailed within 0-6 h: $19.90)

Accession: 055579376

Download citation: RISBibTeXText

PMID: 22008107

DOI: 10.3779/j.issn.1009-3419.2011.10.03


Related references

Risk factors and prognosis of pulmonary embolism in patients with lung cancer. Medicine 96(16): E6638-E6638, 2017

Prevalence and Risk Factors of Acute Pulmonary Embolism in Patients with Lung Cancer Surgery. Seminars in Thrombosis and Hemostasis: -, 2018

Erratum to pulmonary embolism concurrent with lung cancer and central emboli predict mortality in patients with lung cancer and pulmonary embolism. Journal of Thoracic Disease 10(3): E242-E242, 2018

Pulmonary embolism concurrent with lung cancer and central emboli predict mortality in patients with lung cancer and pulmonary embolism. Journal of Thoracic Disease 10(1): 262-272, 2018

Comparing the pulmonary embolism severity index and the prognosis in pulmonary embolism scores as risk stratification tools. Journal of Hospital Medicine 7(1): 22-27, 2015

Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Experimental and Clinical Cardiology 18(2): 129-138, 2013

Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome. Acta Obstetricia et Gynecologica Scandinavica 83(6): 576-585, 2004

Unsuspected pulmonary embolism in lung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer 78(2): 161-166, 2013

Factors influencing prognosis of pulmonary resection in elderly lung cancer patients. Zhonghua Jie He He Hu Xi Za Zhi 10(1): 4-7, 61, 1987

The influencing factors of near prognosis of pulmonary resection on elderly lung cancer patients. Chinese Journal of Tuberculosis & Respiratory Diseases 10(1): 4-7, 61, 1987

Utility of Inferior Vena Cava Filters in Severe Pulmonary Embolism, Catheter-directed Therapy in Massive and Submassive Pulmonary Embolism, and HAS-BLED Score to Determine Risk of Major Hemorrhage in Pulmonary Embolism. American Journal of Respiratory and Critical Care Medicine 193(11): 1301-1303, 2016

Risk factors and clinical outcome of unsuspected pulmonary embolism in cancer patients: a case-control study. Journal of Thrombosis and Haemostasis 10(10): 2032-2038, 2013

Bronchopleural fistulas developing after pulmonary resections for lung cancer predisposing factors, management, and prognosis. Nihon Kyobu Geka Gakkai 39(10): 1894-1901, 1991

Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respiratory Medicine 108(3): 524-530, 2014

Combined helical computed tomographic pulmonary angiography and lung perfusion scintigraphy for investigating acute pulmonary embolism. Clinical Radiology 57(1): 33-36, 2002